Yu Liang Selected Research

Yu Liang Research Topics

Disease

72	Neoplasms (Cancer) 07/2022 - 12/2002
16	Infections 07/2022 - 09/2003
11	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2014
11	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2018
10	Reperfusion Injury 01/2022 - 12/2013
9	Inflammation (Inflammations) 06/2022 - 01/2004
9	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 09/2008
8	Ischemia 06/2022 - 12/2013
8	Carcinogenesis 01/2022 - 09/2008
7	Brain Ischemia (Cerebral Ischemia) 01/2022 - 12/2011
7	Carcinoma (Carcinomatosis) 03/2020 - 03/2012
6	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2012
5	Alzheimer Disease (Alzheimer's Disease) 06/2021 - 01/2004
5	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2016
5	Breast Neoplasms (Breast Cancer) 04/2020 - 01/2012
4	Hypoxia (Hypoxemia) 01/2022 - 07/2010
4	Graves Ophthalmopathy 01/2021 - 01/2020
4	Spinal Cord Ischemia 01/2019 - 01/2017
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 06/2002
4	Atherosclerosis 12/2018 - 08/2004
4	Glioma (Gliomas) 08/2014 - 07/2005
4	Pain (Aches) 01/2014 - 07/2009
3	Anemia 04/2022 - 10/2019
3	Diarrhea 02/2022 - 10/2019
3	Esophageal Squamous Cell Carcinoma 01/2022 - 06/2014
3	Brain Injuries (Brain Injury) 01/2022 - 12/2012
3	Hypertension (High Blood Pressure) 01/2022 - 04/2004
3	Esophageal Neoplasms (Esophageal Cancer) 12/2021 - 06/2014
3	Wounds and Injuries (Trauma) 07/2021 - 10/2013
3	Fibrosis (Cirrhosis) 01/2021 - 01/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2020 - 05/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 10/2011
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 12/2011
3	Colonic Neoplasms (Colon Cancer) 07/2019 - 05/2016
3	Schistosomiasis (Bilharziasis) 11/2017 - 11/2004
3	Lung Neoplasms (Lung Cancer) 01/2017 - 12/2008
3	Glioblastoma (Glioblastoma Multiforme) 01/2008 - 02/2005
2	Ischemic Stroke 06/2022 - 12/2020
2	Malaria 02/2022 - 01/2022
2	Colitis 02/2022 - 04/2014
2	Insulin Resistance 01/2022 - 01/2003
2	Liver Diseases (Liver Disease) 01/2022 - 12/2012
2	Ganglion Cysts (Ganglion) 10/2021 - 02/2013
2	Parkinson Disease (Parkinson's Disease) 08/2021 - 01/2016

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2002
15	MicroRNAs (MicroRNA)IBA 07/2022 - 03/2007
14	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2003
12	Pharmaceutical PreparationsIBA 02/2022 - 11/2009
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2011
10	Messenger RNA (mRNA)IBA 12/2021 - 02/2004
9	EnzymesIBA 08/2020 - 11/2009
8	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 01/2004
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2005
7	6-methyladenineIBA 01/2022 - 11/2018
7	VaccinesIBA 12/2021 - 06/2002
6	ChromatinIBA 01/2022 - 11/2009
6	Long Noncoding RNAIBA 01/2022 - 11/2018
6	MethyltransferasesIBA 01/2022 - 11/2018
6	Competitive Endogenous RNAIBA 10/2020 - 11/2018
5	CytokinesIBA 06/2022 - 01/2015
5	AntioxidantsIBA 01/2022 - 12/2011
5	salicylhydroxamic acid (SHAM)IBA 01/2017 - 12/2011
4	Neuroprotective AgentsIBA 06/2022 - 09/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 11/2008
4	Tyrosine Kinase InhibitorsIBA 09/2020 - 01/2019
4	Transcription Factors (Transcription Factor)IBA 10/2018 - 07/2010
3	Metformin (Glucophage)FDA LinkGeneric 07/2022 - 11/2020
3	CalciumIBA 04/2022 - 01/2017
3	Phosphorus (Red Phosphorus)IBA 04/2022 - 02/2015
3	Circular RNAIBA 01/2022 - 01/2020
3	CreatinineIBA 01/2022 - 04/2012
3	Uric Acid (Urate)IBA 01/2022 - 04/2013
3	InterleukinsIBA 01/2021 - 01/2014
3	Troleandomycin (TAO)FDA Link 01/2021 - 01/2020
3	ErbB Receptors (EGF Receptor)IBA 04/2020 - 04/2006
3	LipidsIBA 01/2020 - 12/2011
3	Peptides (Polypeptides)IBA 10/2019 - 11/2008
3	Indicators and Reagents (Reagents)IBA 01/2019 - 05/2013
3	Interleukin-10 (Interleukin 10)IBA 01/2017 - 12/2011
3	Sevoflurane (Ultane)FDA LinkGeneric 09/2015 - 12/2011
3	AntigensIBA 01/2015 - 11/2004
3	UromodulinIBA 12/2013 - 04/2012
3	Histones (Histone)IBA 02/2013 - 11/2009
3	Liver X ReceptorsIBA 04/2012 - 02/2004
3	Viral ProteinsIBA 04/2006 - 12/2003
2	artemisinin (artemisinine)IBA 02/2022 - 01/2022
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 06/2010
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 05/2014
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2022
2	NitrogenIBA 01/2022 - 05/2014
2	Antiviral Agents (Antivirals)IBA 10/2021 - 02/2013
2	Sirolimus (Rapamycin)FDA Link 08/2021 - 08/2020
2	SynucleinsIBA 08/2021 - 01/2016

Therapy/Procedure

23	Therapeutics 02/2022 - 09/2003
9	Drug Therapy (Chemotherapy) 04/2020 - 09/2003
4	Ischemic Postconditioning 06/2022 - 12/2020
4	Radiotherapy 01/2022 - 01/2008
3	Lasers (Laser) 01/2022 - 02/2020
2	Peritoneal Dialysis 04/2022 - 01/2022
2	Chemoradiotherapy 01/2022 - 01/2021